What medications can be given to a patient with an allergic reaction after administering epinephrine (adrenaline) to help alleviate symptoms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Allergic Reactions After Epinephrine Administration

After administering epinephrine for an allergic reaction, additional medications including H1 antihistamines, H2 antihistamines, corticosteroids, and bronchodilators should be given to help alleviate symptoms and prevent biphasic reactions.

First-Line Treatment Reminder

  • Epinephrine is the first-line treatment for anaphylaxis and should never be delayed 1
  • Administered intramuscularly in the anterolateral thigh at 0.01 mg/kg (1:1000 solution), up to 0.3 mg in children and 0.3-0.5 mg in adults 2
  • Can be repeated every 5-15 minutes if symptoms persist 2, 1

Secondary Medications (After Epinephrine)

H1 Antihistamines

  • Diphenhydramine 1-2 mg/kg or 25-50 mg IV/IM in adults 2, 1
  • Effective for cutaneous symptoms (urticaria, angioedema, pruritus)
  • Note: H1 antihistamines are second-line therapy and should never be administered alone in anaphylaxis 2

H2 Antihistamines

  • Ranitidine 50 mg IV in adults and 12.5-50 mg (1 mg/kg) in children 2
  • Can be diluted in 5% dextrose to 20 mL and injected over 5 minutes
  • Combination of H1 and H2 antagonists is superior to H1 antagonists alone 2

Corticosteroids

  • Consider systemic glucocorticosteroids for patients with:
    • History of idiopathic anaphylaxis
    • Asthma
    • Severe or prolonged anaphylaxis 2
  • IV glucocorticosteroids: 1-2 mg/kg/day equivalent, administered every 6 hours 2
  • Oral prednisone (0.5 mg/kg) may be sufficient for less critical episodes 2
  • Note: Corticosteroids have slow onset and are not helpful acutely but may prevent recurrent/biphasic reactions 2

Bronchodilators

  • For persistent bronchospasm resistant to epinephrine:
  • Nebulized albuterol 2.5-5 mg in 3 mL saline, repeated as necessary 2

Management of Specific Complications

Refractory Hypotension

  • Continue fluid resuscitation with normal saline (1-2 L at 5-10 mL/kg in first 5 minutes) 2
  • For hypotension unresponsive to epinephrine and fluids, consider vasopressor infusion:
    • Dopamine (400 mg in 500 mL of 5% dextrose) at 2-20 μg/kg/min 2
    • Titrate to maintain systolic BP >90 mmHg 2

For Patients on Beta-Blockers

  • Consider glucagon if standard treatment is ineffective
  • Dosage: 1-5 mg IV over 5 minutes, followed by infusion (5-15 μg/min) 2

Monitoring and Observation

  • Monitor vital signs until complete resolution of symptoms 2
  • Observe for at least 4-6 hours after symptom resolution due to risk of biphasic reactions 1
  • Severe reactions may require 24-hour observation 2

Special Considerations

  • Recent research supports the beneficial effect of both epinephrine and antihistamines in managing allergic reactions 3
  • The combination of diphenhydramine and ranitidine is superior to diphenhydramine alone but should never replace epinephrine 2
  • Patients with history of severe reactions should be prescribed epinephrine auto-injectors upon discharge 1, 4

Common Pitfalls to Avoid

  • Delaying epinephrine administration (associated with fatal outcomes) 2
  • Using antihistamines or corticosteroids as substitutes for epinephrine 2, 1
  • Failing to monitor patients adequately for biphasic reactions 2
  • Not addressing respiratory symptoms with bronchodilators when needed 2
  • Underestimating the psychological impact of allergic reactions (43% of patients report fear for their lives) 5

By following this algorithmic approach to managing allergic reactions after epinephrine administration, clinicians can effectively reduce morbidity and mortality while improving patient outcomes.

References

Guideline

Anaphylaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Managing anaphylaxis: Epinephrine, antihistamines, and corticosteroids: More than 10 years of Cross-Canada Anaphylaxis REgistry data.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.